Welcome Back
Join CoinTime
Sign in with email
Sign up with email
Check your inbox
Rocket Pharmaceuticals
About
Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.
- Cranbury,New Jersey,United States
- 101 - 250
- http://www.rocketpharma.com/
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $100.30M
- Industries
- Biotechnology,Genetics,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2015
- Number Of Employee
- 101 - 250
- Operating Status
- Active
- Stock Symbol
- nasdaq:RCKT
- Legal Name
- Rocket Pharmaceuticals, Inc.
- Also Known As
- Rocket Pharmaceuticals Ltd.
Rocket Pharmaceuticals is a biotechnology company that is working to develop first-in-class gene therapy treatments for rare and undertreated diseases. The Company's lead program is a lentiviral-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult-to-treat genetic disease that causes bone marrow failure and, in the worst-case scenario, cancer. Additional bone marrow-derived disorders are being studied in preclinical trials, including Pyruvate Kinase Deficiency (PKD), Leukocyte Adhesion Deficiency-1 (LAD-1), and Infantile Malignant Osteopetrosis. In addition, the company is working on an AAV-based gene therapy program for an unnamed rare pediatric disease.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 3, 2022 | Post-IPO Equity | $100.30M | — | — | — | Detail |
| Aug 30, 2021 | Post-IPO Equity | $26.40M | 1 |
RTW Investments
|
— | Detail |
| Dec 9, 2020 | Post-IPO Equity | $299M | 1 | — | — | Detail |
| Nov 13, 2020 | Grant | $3.70M | 1 |
California Institute of Regenerative Medicine (CIRM)
|
— | Detail |
| Dec 10, 2019 | Post-IPO Equity | $84.99M | — | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
RTW Investments
|
Yes | Post-IPO Equity |
|
California Institute of Regenerative Medicine (CIRM)
|
Yes | Grant |
Frazier Healthcare Partners
|
— | Post-IPO Equity |
Civilization Ventures
|
— | Post-IPO Equity |
|
|
— | Post-IPO Equity |
Employee Profiles
Acquisition
Rocket Pharmaceuticals has acquired 2 organizations. Their most recent acquisition was Inotek Pharmaceuticals on Sep 12, 2017. They acquired Inotek Pharmaceuticals for 0.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Sep 12, 2017
Inotek Pharmaceuticals
|
Biotechnology | acquisition | — | Detail |
|
Sep 20, 2022
Renovacor
|
Biotechnology | acquisition | — | Detail |
